Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Researchers Point To MedTech Overuse Amid Reform Debate

This article was originally published in The Gray Sheet

Executive Summary

Several academic research teams highlighted cases of overuse of medical technologies last week, just as the device industry is stepping up efforts to remove itself from the crosshairs of policymakers looking to cut spending and raise revenues as part of health care reform

You may also be interested in...



Analysis Questions Value Of Robotic Prostate Surgery

Minimally invasive removal of the prostate has some advantages, but it does not measure up to traditional open surgery in preventing incontinence and erectile dysfunction, Harvard researchers reported in the Journal of the American Medical Association Oct. 14

Finance Dems Block Move To Strip Device Fee, But Signal Room To Negotiate

An amendment that would have stripped a proposed $4 billion annual fee on device manufacturers from health care reform legislation was voted down by Senate Finance Committee Democrats Oct. 1, but they signaled an interest to negotiate further

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

Topics

UsernamePublicRestriction

Register

MT028066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel